09 Nov Staying on Track: What the GLP-1 Withdrawal Trials Mean for Patients Who Move or Travel Abroad
Prescription Medication Notice: Semaglutide and tirzepatide are prescription medications and should only be prescribed and monitored by your healthcare provider. Do not stop, restart or change your dose without medical advice. Buy medicines only from licensed pharmacies with a valid local prescription, and check the rules for carrying or importing prescription medicines before you travel. These medicines are not used during pregnancy and are not suitable for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Seek urgent care for severe or persistent abdominal pain, signs of dehydration, or swelling of the face, lips or throat.
MedicalResearch.com Interview with: Dr. Pedro Yelamo Vera, MD General Practitioner, licensed in Spain (Official College of Physicians of Bizkaia) Dr. Yelamo runs an independent telemedicine practice for English- and Spanish-speaking patients.
Editorial Notice: This interview is general information and is not specific medical advice. Dr. Yelamo runs a private telemedicine practice, disclosed below. Providers named or linked in this article are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc.
Dr. Tatum[/caption]
Kristina L. Tatum, PsyD, MS
Instructor
Department of Social and Behavioral Sciences
School of Public Health
A large population-based analysis of more than 841,000 breast cancer patients across the United States examines whether GLP-1 receptor agonist use is associated with improved survival and lower recurrence risk — with findings that researchers describe as very promising.
Dr. Donofry[/caption]
Shannon D. Donofry Ph.D.
Behavioral Scientist
B.A.Sc. in psychology/neuroscience
University of Pittsburgh-Pittsburgh Campus;
Ph.D, University of Pittsburgh-Pittsburgh Campus
[caption id="attachment_70207" align="alignleft" width="125"]
Dr. Rancaño[/caption]
Katherine M. Rancaño, Ph.D
Associate Policy Researcher
RAND
MedicalResearch.com: What is the background for this study?
Response: GLP-1 medications were first used to help people with diabetes manage their blood sugar. Lately, they’ve become popular for helping people lose weight, too. Because of this, a lot more people have started using them. In our study, we asked over 8,000 adults from across the country about their use of GLP-1 medications and any side effects they had.
Prof. El GHOCH[/caption]
MedicalResearch.com Interview with:
Prof. Marwan EL GHOCH